Showing results (101-110 of 147) with videos related to
Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1980
Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinomaY C Cheng, J Y Chen, R Glaser, et al.International Journal of Cancer|July 15, 1976
Anti-EBV antibody titers in non-Hodgkin lymphomasJ Dumont, A Liabeuf, W Henle, et al.Journal of the National Cancer Institute|March 1, 1981
Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studiesR J Biggar, F K Nkrumah, W Henle, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1977
Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cellsR Glaser, D V Ablashi, M Nonoyama, et al.The Journal of Experimental Medicine|October 30, 2009
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA AL A Chambers, W Henle, M A Lauffer, et al.International Journal of Cancer|June 15, 1979
Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patientsM Andersson-Anvret, N Forsby, G Klein, et al.Cellular Immunology|July 1, 1984
T-lymphocyte subset interactions in the cell-mediated immune response to Epstein-Barr virusR T Schooley, D I Arbit, W Henle, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivoC M Edson, L K Cohen, W Henle, et al.Pediatrics|June 1, 1983
Transient immunodeficiency during asymptomatic Epstein-Barr virus infectionT J Bowen, R J Wedgwood, H D Ochs, et al.Cancer|January 15, 1983
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinomaG R Pearson, L H Weiland, H B Neel, et al.Pageof 15